Immunology of Normal Pregnancy and Preeclampsia

Chesley's Hypertensive Disorders in Pregnancy

Volumn , Issue , 2009, Pages 129-142

  Redman, Christopher W G ^a   Sargent, Ian L ^b   Roberts, James M ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953938110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374213-1.00008-2     Document Type: Chapter

References (121)

1. W.D. Billington (2003) The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol 60 1-11.
2. J.G. Feeney and J.S. Scott (1980) Pre-eclampsia and changed paternity. Eur J Obstet Gynecol Reprod Biol 11 35-38.
3. P.Y. Robillard, T.C. Hulsey, G.R. Alexander, A. Keenan, F. de Caunes and E. Papiernik (1993) Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 24 1-12.
4. J. Zhang and G. Patel (2007) Partner change and perinatal outcomes: a systematic review. Paediatr Perinat Epidemiol 21(Suppl 1), 46-57.
5. O. Basso, K. Christensen and J. Olsen (2001) Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology 12 624-629.
6. R. Skjaerven, A.J. Wilcox and R.T. Lie (2002) The interval between pregnancies and the risk of preeclampsia. N Eng J Med 346 33-38.
7. J. Zhang (2007) Partner change, birth interval and risk of pre-eclampsia: a paradoxical triangle. Paediatr Perinat Epidemiol 21(Suppl 1), 31-35.
8. P.Y. Robillard, G. Dekker, G. Chaouat and T.C. Hulsey (2007) Etiology of preeclampsia: maternal vascular predisposition and couple disease – mutual exclusion or complementarity? J Reprod Immunol 76 1-7.
9. G. Dekker (2002) The partner's role in the etiology of preeclampsia. J Reprod Immunol 57 203-215.
10. S. Saito, M. Sakai, Y. Sasaki, A. Nakashima and A. Shiozaki (2007) Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 76 30-39.
11. P.Y. Robillard and T.C. Hulsey (1996) Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet 347 619-1619.
12. P. Matzinger (2002) The danger model: A renewed sense of self. Science 296 301-305.
13. S. Gordon (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111 927-930.
14. D.M. Noonan, A. De Lerma Barbaro, N. Vannini, L. Mortara and A. Albini (2008) Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 27 31-40.
15. K. Hensley, K.A. Robinson, S.P. Gabbita, S. Salsman and R.A. Floyd (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28 1456-1462.
16. J.P. Bastard, M. Maachi, C. Lagathu, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 4-12.
17. K.S. Ahn and B.B. Aggarwal (2005) Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 1056 218-233.
18. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel and M.K. McLaughlin (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 1200-1204.
19. K.Y. Stokes and D.N. Granger (2005) The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol 562 647-653.
20. P. Trayhurn and I.S. Wood (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 347-355.
21. D. Ribatti, M.T. Conconi and G.G. Nussdorfer (2007) Nonclassic endogenous novel regulators of angiogenesis. Pharmacol Rev 59 185-205.
22. Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban and J. Egido (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35 881-900.
23. Q. Zhao, M. Ishibashi, K. Hiasa, C. Tan, A. Takeshita and K. Egashira (2004) Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44 264-270.
24. P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty and G. Rajesh (2004) A novel view of metabolic syndrome. Metab Syndr Relat Disord 2 2-8.
25. C. Gabay and I. Kushner (1999) Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340 448-454.
26. M.B. Pepys and G.M. Hirschfield (2003) C-reactive protein: a critical update. J Clin Invest 111 1805-1812.
27. J.Y. Yoo and S. Desiderio (2003) Innate and acquired immunity intersect in a global view of the acute-phase response. Proc Natl Acad Sci USA 100 1157-1162.
28. H.W. Harris, J.E. Gosnell and Z.L. Kumwenda (2001) The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 6 421-430.
29. J.K. Sethi and G.S. Hotamisligil (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10 19-29.
30. G. Matarese, S. Moschos and C.S. Mantzoros (2005) Leptin in immunology. J Immunol 174 3137-3231.
31. P. Ziccardi, F. Nappo, G. Giugliano, et al. (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105 804-809.
32. B. Isomaa (2003) A major health hazard: the metabolic syndrome. Life Sci 73 2395-2411.
33. G.K. Hansson, P. Libby, U. Schünbeck and Z.Q. Yan (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 281-291.
34. I.L. Sargent, A.M. Borzychowski and C.W. Redman (2006) NK cells and human pregnancy – an inflammatory view. Trends Immunol 27 399-404.
35. H.G Ljunggren and K. Karre (1990) In search of the missing self: MHC molecules and NK recognition. Immunol Today 11 237-244.
36. J.S. Hunt (2006) Stranger in a strange land. Immunol Rev 213 36-47.
37. J. Hanna, D. Goldman-Wohl, Y. Hamani, et al. (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 1065-1074.
38. C.S. Clements, L. Kjer-Nielsen, J. McCluskey and J. Rossjohn (2007) Structural studies on HLA-G: implications for ligand and receptor binding. Hum Immunol 68 220-226.
39. P. Parham (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 201-214.
40. S. Rajagopalan and E.O. Long (2005) Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201 1025-1029.
41. S.E. Hiby, J.J. Walker, K.M. O'Shaughnessy, C.W. Redman, M. Carrington, J. Trowsdale and A. Moffett (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 957-965.
42. A. Moffett and S.E. Hiby (2007) How does the maternal immune system contribute to the development of pre-eclampsia? Placenta 28(Suppl A), S51-S56.
43. J.R. Wilczynski (2006) Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia – the same basic mechanism? Hum Immunol 67 492-511.
44. S.E. Hiby, L. Regan, W. Lo, L. Farrell, M. Carrington and A. Moffett (2008) Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 23 972-976.
45. C. Willis, J.M. Morris, V. Danis and E.D. Gallery (2003) Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle. Hum Reprod 18 1173-1178.
46. J.W. Studd, J.D. Blainey and D.E. Bailey (1970) Serum protein changes in the pre-eclampsia-eclampsia syndrome. J Obstet Gynaecol Br Commonw 77 796-801.
47. L. Gatti, P.M. Tenconi, D. Guarneri, C. Bertulessi, M.W. Ossola, P. Bosco and G.A. Gianotti (1994) Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 24 217-219.
48. C.W. Redman and I.L. Sargent (2004) Pre-eclampsia and the systemic inflammatory response. M. Belfort, F. Lyall (Eds) Pre-eclampsia – Aetiology and Clinical Practice Cambridge, England: Cambridge University Press 103-120.
49. G.P. Sacks, L. Seyani, S. Lavery and G. Trew (2004) Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 19 1025-1030.
50. A.K. Smarason, A. Gunnarsson, J.H. Alfredsson and H. Valdimarsson (1986) Monocytosis and monocytic infiltration of decidua in early pregnancy. J Clin Lab Immunol 21 1-5.
51. G.P. Sacks, K. Studena, K. Sargent and C.W. Redman (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 80-86.
52. C.W. Redman, G.P. Sacks and I.L. Sargent (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 499-506.
53. G.S. Vince, P.M. Starkey, R. Austgulen, D. Kwiatkowski and C.W. Redman (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102 20-25.
54. R.M. Pitkin and D.L. Witte (1979) Platelet and leukocyte counts in pregnancy. JAMA 242 2696-2698.
55. K. Richani, E. Soto, R. Romero, et al. (2005) Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 17 239-245.
56. P. Chabloz, G. Reber, F. Boehlen, P. Hohlfeld and P. de Moerloose (2001) TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 115 150-152.
57. S.L. Janes and A.H. Goodall (1994) Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci Colch 86 731-739.
58. J.D. Sørensen, N.J. Secher and J. Jespersen (1995) Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function. Acta Obstet Gynecol Scand 74 257-261.
59. L. Belo, M. Caslake, A. Santos-Silva, E.M. Castro, L. Pereira-Leite, A. Quintanilha and I. Rebelo (2004) LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 177 391-399.
60. R.E. Little and B.C. Gladen (1999) Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 13 347-352.
61. V.M. Victor, M. Rocha, J.V. Esplugues and M. De la Fuente (2005) Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 11 3141-3158.
62. J. Rius, M. Guma, C. Schachtrup, et al. (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 807-811.
63. G. Krishnaswamy, J. Kelley, L. Yerra, J.K. Smith and D.S. Chi (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19 91-104.
64. T.G. Wegmann, H. Lin, L. Guilbert and T.R. Mosmann (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14 353-356.
65. D. Peritt, S. Robertson, G. Gri, L. Showe, M. Aste-Amezaga and G. Trinchieri (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161 5821-5824.
66. P.T. Lee, K. Benlagha, L. Teyton and A. Bendelac (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 195 637-641.
67. S. Saito, M. Sakai, Y. Sasaki, K. Tanebe, H. Tsuda and T. Michimata (1999) Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 117 550-555.
68. M. Marzi, A. Vigano, D. Trabattoni, M.L. Villa, A. Salvaggio, E. Clerici and M. Clerici (1996) Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106 127-133.
69. J.R. Wilczynski, H. Tchorzewski, M. Banasik, et al. (2003) Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 109 8-15.
70. A.M. Borzychowski, B.A. Croy, W.L. Chan, C.W. Redman and I.L. Sargent (2005) Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol 35 3054-3063.
71. G.P. Sacks, C.W. Redman and I.L. Sargent (2003) Monocytes are primed to express the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 131 490-497.
72. I.L. Sargent, A.M. Borzychowski and C.W. Redman (2007) NK cells and pre-eclampsia. J Reprod Immunol 76 40-44.
73. S. Saito, A. Shiozaki, A. Nakashima, M. Sakai and Y. Sasaki (2007) The role of the immune system in preeclampsia. Mol Aspects Med 28 192-209.
74. D.A. Terrone, B.K. Rinehart, W.L. May, A. Moore, E.F. Magann and N.J. Martin (2000) Leukocytosis is proportional to HELLP syndrome severity: evidence for an inflammatory form of preeclampsia. South Med J 93 768-771.
75. I.J. de Messias-Reason, V. Aleixo, H. de Freitas, R.M. Nisihara, V. Mocelin and A. Urbanetz (2000) Complement activation in Brazilian patients with preeclampsia. J Investig Allergol Clin Immunol 10 209-214.
76. K.P. Conrad, T.M. Miles and D.F. Benyo (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40 102-111.
77. J. Ellis, U.B. Wennerholm, A. Bengtsson, et al. (2001) Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80 602-608.
78. P.H. Park, H. Huang, M.R. McMullen, P. Mandal, L. Sun and L.E. Nagy (2008) Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms. J Biol Chem 283 26850-26858.
79. M.M. Faas, G.A. Schuiling, J.F. Baller, C.A. Visscher and W.W. Bakker (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171 158-164.
80. L.S. Angelo and R. Kurzrock (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13 2825-2830.
81. P.N. Tsao, F.T. Chan, S.C. Wei, et al. (2007) Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit Care Med 35 1955-1960.
82. S. Ahmad and A. Ahmed (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95 884-891.
83. S.K. Selvaraj, R.K. Giri, N. Perelman, C. Johnson, P. Malik and V.K. Kalra (2003) Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102 1515-1524.
84. U. Manuelpillai, M. Schneider-Kolsky, P. Thirunavukarasu, A. Dole, K. Waldron and E.M. Wallace (2003) Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis. Placenta 24 77-83.
85. K.L. Jones, A. Mansell, S. Patella, B.J. Scott, M.P. Hedger, D.M. de Kretser and D.J. Phillips (2007) Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104 16239-16244.
86. P.A. Fowler, L.W. Evans, N.P. Groome, A. Templeton and P.G. Knight (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod 13 3530-3536.
87. A.V. Perkins and E.A. Linton (1995) Identification and isolation of corticotrophin-releasing hormone-positive cells from the human placenta. Placenta 16 233-243.
88. K. Karalis, H. Sano, J. Redwine, S. Listwak, R.L. Wilder and G.P. Chrousos (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254 421-423.
89. A.V. Perkins, E.A. Linton, F. Eben, J. Simpson, C.D. Wolfe and C.W. Redman (1995) Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 102 118-122.
90. A.B. Zavalza-Gómez, R. Anaya-Prado, A.R. Rincón-Sánchez and J.M. Mora-Martínez (2008) Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 80 8-15.
91. P. Fons, S. Chabot, J.E. Cartwright, et al. (2006) Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108 2608-2615.
92. C.W. Redman and I.L. Sargent (2008) Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 29(Suppl A), S73-S77.
93. C.W. Redman and I.L. Sargent (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta 21 597-602.
94. R.J. Berckmans, R. Neiuwland, A.N. Böing, F.P. Romijn, C.E. Hack and A. Sturk (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85 639-646.
95. A.K. Smarason, I.L. Sargent, P.M. Starkey and C.W. Redman (1993) The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 100 943-949.
96. P. von Dadelszen, G. Hurst and C.W. Redman (1999) Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod 14 919-924.
97. S.J. Germain, G.P. Sacks, S.R. Soorana, I.L. Sargent and C.W. Redman (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178 5949-5956.
98. D. Goswami, D.S. Tannetta, L.A. Magee, A. Fuchisawa, C.W. Redman, I.L. Sargent and P. von Dadelszen (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27 56-61.
99. N. Cester, R. Staffolani, R.A. Rabini, et al. (1994) Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem 131 151-155.
100. Y. Kudo, C.A. Boyd, I.L. Sargent and C.W. Redman (2003) Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am J Obstet Gynecol 188 719-726.
101. R. Apps, L. Gardner and A. Moffett (2008) A critical look at HLA-G. Trends Immunol 29 313-321.
102. I.L. Sargent (2005) Does ‘soluble’ HLA-G really exist? Another twist to the tale. Mol Hum Reprod 11 695-698.
103. P. Le Bouteiller, N. Pizzato, A. Barakonyi and C. Solier (2003) HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 59 219-234.
104. A. Blaschitz, H. Juch, A. Volz, H. Hutter, C. Daxboeck, G. Desoye and G. Dohr (2005) The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms. Mol Hum Reprod 11 699-710.
105. R. Hackmon, A. Koifman, H. Hyodo, H. Glickman, E. Sheiner and D.E. Geraghty (2007) Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 197 255.e1–5
106. S. Sakaguchi, T. Yamaguchi, T. Nomura and M. Ono (2008) Regulatory T cells and immune tolerance. Cell 133 775-787.
107. V.R. Aluvihare, M. Kallikourdis and A.G. Betz (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5 266-271.
108. L. Arruvito, M. Sanz, A.H. Banham and L. Fainboim (2007) Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 178 2572-2578.
109. D.A. Somerset, Y. Zheng, M.D. Kilby, D.M. Sansom and M.T. Drayson (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25 CD4 regulatory T-cell subset. Immunology 112 38-43.
110. T. Tilburgs, D.L. Roelen, B.J. van der Mast, G.M. de Groot-Swings, C. Kleijburg, S.A. Scherjon and F.H. Claas (2008) Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 180 5737-5745.
111. A. Steinborn, G.M. Haensch, K. Mahnke, E. Schmitt, A. Toermer, S. Meuer and C. Sohn (2008) Distinct subsets of regulatory T cells during pregnancy: Is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 129 401-412.
112. D. Hu, Y. Chen, W. Zhang, H. Wang, Z. Wang and M. Dong (2008) Alteration of peripheral CD4+CD25+ regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 87 190-194.
113. M. Visser, L.M. Bouter, G.M. McQuillan, M.H. Wener and T.B. Harris (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 2131-2135.
114. J.C. Pickup, G.D. Chusney, S.M. Thomas and D. Burt (2000) Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67 291-300.
115. F. Lacy, D.T. O’Connor and G.W. Schmid-Schönbein (1998) Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16 291-303.
116. R.M. Mazar, S.K. Srinivas, M.D. Sammel, C.M. Andrela and M.A. Elovitz (2007) Metabolic score as a novel approach to assessing preeclampsia risk. Am J Obstet Gynecol 197 411.e1–5
117. V.A. Rodie, D.J. Freeman, N. Sattar and I.A. Greer (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175 189-202.
118. J.K. Nien, S. Mazaki-Tovi, R. Romero, et al. (2007) Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 35 513-521.
119. A. Conde-Agudelo, J. Villar and M. Lindheimer (2008) Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 198 7-22.
120. G.D. Slade, E.M. Ghezzi, G. Heiss, J.D. Beck, E. Riche and S. Offenbacher (2003) Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 163 1172-1179.
121. M. Ruma, K. Boggess, K. Moss, H. Jared, A. Murtha, J. Beck and S. Offenbacher (2008) Maternal periodontal disease, systemic inflammation, and risk for preeclampsia. Am J Obstet Gynecol 198 389.e1–5